• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

残余胰腺中的高危病变:胰腺癌和导管内乳头状黏液性肿瘤行胰腺切除术后残余胰腺的转归

High-risk lesions in the remnant pancreas: fate of the remnant pancreas after pancreatic resection for pancreatic cancer and intraductal papillary mucinous neoplasms.

作者信息

Miyasaka Yoshihiro, Ohtsuka Takao, Matsuda Ryota, Mori Yasuhisa, Nakata Kohei, Ohuchida Kenoki, Nakamura Masafumi

机构信息

Department of Surgery and Oncology, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Department of Surgery, Fukuoka University Chikushi Hospital, Chikushino, Japan.

出版信息

Surg Today. 2020 Aug;50(8):832-840. doi: 10.1007/s00595-019-01852-3. Epub 2019 Jul 25.

DOI:10.1007/s00595-019-01852-3
PMID:31346809
Abstract

Progress in diagnostic modalities, surgical procedures, and multidisciplinary treatment for pancreatic diseases has increased the number of long-term survivors after pancreatic resection. Several reports have focused on high-risk lesions (HRLs), including high-grade pancreatic intraepithelial neoplasia (PanIN), pancreatic ductal adenocarcinoma, high-grade intraductal papillary mucinous neoplasm (IPMN), and IPMN with an associated invasive carcinoma, in the remnant pancreas after partial pancreatic resection for pancreatic cancer or IPMN. The etiology of HRLs in the remnant pancreas is thought to be either isolated local recurrence of the initial lesion in the remnant pancreas or a newly developed primary lesion. Although it is difficult to distinguish between local recurrence and a new primary lesion, comparison of genetic alterations between two lesions may help with this distinction. Early detection of HRLs in the remnant pancreas may improve the prognosis of patients, and several investigators have proposed predictive factors for HRLs in the remnant pancreas after partial pancreatic resection for pancreatic cancer or IPMN. The reported short- and long-term outcomes of surgical resection of HRLs in the remnant pancreas are relatively favorable. Life-long surveillance of the remnant pancreas is recommended after partial pancreatic resection for pancreatic cancer or IPMN.

摘要

胰腺疾病诊断方法、手术操作及多学科治疗的进展增加了胰腺切除术后长期存活者的数量。有几份报告聚焦于高危病变(HRLs),包括高级别胰腺上皮内瘤变(PanIN)、胰腺导管腺癌、高级别导管内乳头状黏液性肿瘤(IPMN)以及伴有浸润性癌的IPMN,这些病变出现在因胰腺癌或IPMN行部分胰腺切除术后的残余胰腺中。残余胰腺中HRLs的病因被认为要么是初始病变在残余胰腺中的孤立局部复发,要么是新发生的原发性病变。尽管很难区分局部复发和新的原发性病变,但比较两个病变之间的基因改变可能有助于这种区分。早期检测残余胰腺中的HRLs可能改善患者的预后,并且一些研究人员提出了因胰腺癌或IPMN行部分胰腺切除术后残余胰腺中HRLs的预测因素。报告显示,对残余胰腺中HRLs进行手术切除的短期和长期结果相对良好。对于因胰腺癌或IPMN行部分胰腺切除术后的患者,建议对残余胰腺进行终身监测。

相似文献

1
High-risk lesions in the remnant pancreas: fate of the remnant pancreas after pancreatic resection for pancreatic cancer and intraductal papillary mucinous neoplasms.残余胰腺中的高危病变:胰腺癌和导管内乳头状黏液性肿瘤行胰腺切除术后残余胰腺的转归
Surg Today. 2020 Aug;50(8):832-840. doi: 10.1007/s00595-019-01852-3. Epub 2019 Jul 25.
2
A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.一项关于胰腺分支导管内乳头状黏液性肿瘤手术切除后复发的大型多中心研究。
Minerva Gastroenterol Dietol. 2017 Mar;63(1):50-54. doi: 10.23736/S1121-421X.16.02341-2. Epub 2016 Nov 8.
3
Targeted DNA Sequencing Reveals Patterns of Local Progression in the Pancreatic Remnant Following Resection of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas.靶向DNA测序揭示胰腺导管内乳头状黏液性肿瘤(IPMN)切除术后胰腺残余局部进展模式。
Ann Surg. 2017 Jul;266(1):133-141. doi: 10.1097/SLA.0000000000001817.
4
Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm.导管内乳头状黏液性肿瘤行胰腺部分切除术后残胰高危病变异时性发生的预测因素
Ann Surg. 2016 Jun;263(6):1180-7. doi: 10.1097/SLA.0000000000001368.
5
Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.胰腺内导管乳头状黏液性肿瘤的胰头下切除术。
J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):798-802. doi: 10.1007/s00534-009-0173-8. Epub 2009 Aug 29.
6
Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.胰管腺癌中同时存在的导管内乳头状黏液性肿瘤是残胰新发癌发生的独立预测因素。
Ann Surg. 2020 May;271(5):941-948. doi: 10.1097/SLA.0000000000003060.
7
Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas.208例胰腺导管内乳头状黏液性肿瘤切除术的经验。
Arch Surg. 2008 Jul;143(7):639-46; discussion 646. doi: 10.1001/archsurg.143.7.639.
8
Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.胰腺导管内乳头状黏液性肿瘤:最新经验
Ann Surg. 2004 Jun;239(6):788-97; discussion 797-9. doi: 10.1097/01.sla.0000128306.90650.aa.
9
Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies.基于长期随访研究的胰腺导管内乳头状黏液性肿瘤术后复发危险因素:随访策略建议
J Hepatobiliary Pancreat Sci. 2015 Oct;22(10):757-65. doi: 10.1002/jhbp.280. Epub 2015 Aug 3.
10
Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm.非侵袭性导管内乳头状黏液性肿瘤切除术后残余胰腺的转归
J Am Coll Surg. 2007 May;204(5):987-93; discussion 993-5. doi: 10.1016/j.jamcollsurg.2006.12.040. Epub 2007 Mar 27.

引用本文的文献

1
Clinical impact of epithelial types on postoperative outcomes for intraductal papillary mucinous neoplasms: a multicenter retrospective study.上皮类型对导管内乳头状黏液性肿瘤术后结局的临床影响:一项多中心回顾性研究
J Gastroenterol. 2025 May;60(5):658-670. doi: 10.1007/s00535-025-02225-z. Epub 2025 Feb 18.
2
Association of pancreatic atrophy patterns with intraductal extension of early pancreatic ductal adenocarcinoma: a multicenter retrospective study.胰腺萎缩模式与早期胰腺导管腺癌管内延伸的相关性:一项多中心回顾性研究。
J Gastroenterol. 2024 Dec;59(12):1133-1142. doi: 10.1007/s00535-024-02149-0. Epub 2024 Sep 16.
3
Dilatation of the main pancreatic duct of unknown origin: causes and risk factors of pre-malignancy or malignancy.
不明原因的主胰管扩张:癌前病变或恶性肿瘤的病因和危险因素。
Surg Endosc. 2023 May;37(5):3684-3690. doi: 10.1007/s00464-022-09854-y. Epub 2023 Jan 13.
4
Pre-Operative Imaging and Pathological Diagnosis of Localized High-Grade Pancreatic Intra-Epithelial Neoplasia without Invasive Carcinoma.无浸润性癌的局限性高级别胰腺上皮内瘤变的术前影像学检查与病理诊断
Cancers (Basel). 2021 Feb 24;13(5):945. doi: 10.3390/cancers13050945.
5
Minimally invasive surgery for pancreatic cancer.胰腺癌的微创外科手术。
Surg Today. 2021 Feb;51(2):194-203. doi: 10.1007/s00595-020-02120-5. Epub 2020 Aug 28.
6
Is remnant pancreatic cancer after pancreatic resection more frequent in early-stage pancreatic cancer than in advanced-stage cancer?胰腺癌切除术后的残留胰腺癌在早期胰腺癌中比在晚期癌症中更常见吗?
Ann Gastroenterol Surg. 2020 May 5;4(4):448-454. doi: 10.1002/ags3.12340. eCollection 2020 Jul.